Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
A compared with HBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
A
Agilent Technologies, Inc.
Change
Mkt cap
Revenue
Revenue
HBIO
Harvard Bioscience Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
A
Agilent Technologies, Inc.
vs
HBIO
Harvard Bioscience Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
A
Agilent Technologies, Inc.
Change
177.37
· pre 179.90
· delayed
Mkt cap
$49.5B
Revenue
$1.9B
Q3 FY26
Revenue
$6.9B
FY25
HBIO
Harvard Bioscience Inc
Change
8.57
· pre 8.60
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$39.2M
Revenue
$23M
Q2 FY26
Revenue
$87M
FY25
vs
Compare
Pre-market
Nov 5 '26
delayed
A
Agilent Technologies, Inc.
vs
HBIO
Harvard Bioscience Inc
177.37
pre 179.90
delayed
Price
8.57
pre 8.60
delayed
$49.5B
Mkt cap
$39.2M
Q3 FY26
$1.9B
Revenue
$23M
Q2 FY26
FY25
$6.9B
Revenue
$87M
FY25
Change
Change
A
177.37
vs
HBIO
8.57
Pre-market
Nov 5 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
HBIO: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only A
2
ALNY
Alnylam Pharmaceuticals
customer
WGS
GeneDx
customer
Shared
0
No shared counterparties.
Only HBIO
1
—
Harvard University
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
A, solid
HBIO, dashed